271 related articles for article (PubMed ID: 35774916)
1. Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review.
Haddad HW; Boardman E; Williams B; Mouhaffel R; Kaye AM; Kaye AD
Health Psychol Res; 2022; 10(3):34224. PubMed ID: 35774916
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder.
Pham H; Warlick H; Bermudez R; Nguyen Q; Rey JA
J Pharm Technol; 2022 Oct; 38(5):304-313. PubMed ID: 36046346
[TBL] [Abstract][Full Text] [Related]
3. Samidorphan/olanzapine combination therapy for schizophrenia: Efficacy, tolerance and adverse outcomes of regimen, evidence-based review of clinical trials.
Rehan ST; Siddiqui AH; Khan Z; Imran L; Syed AA; Tahir MJ; Jassani Z; Singh M; Asghar MS; Ahmed A
Ann Med Surg (Lond); 2022 Jul; 79():104115. PubMed ID: 35860157
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?
Faden J; Serdenes R; Citrome L
Expert Rev Neurother; 2022 May; 22(5):365-376. PubMed ID: 35354374
[TBL] [Abstract][Full Text] [Related]
5. Samidorphan for the treatment of weight gain associated with olanzapine in patients with schizophrenia and bipolar disorder.
Gao J; Li J; Lu X; Yang J
Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1011-1016. PubMed ID: 36016507
[TBL] [Abstract][Full Text] [Related]
6. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
7. An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder.
Citrome L; Graham C; Simmons A; Jiang Y; Todtenkopf MS; Silverman B; DiPetrillo L; Cummings H; Sun L; McDonnell D
Neuropsychiatr Dis Treat; 2021; 17():2885-2904. PubMed ID: 34526769
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.
Corrao MM; Nelson LA
CNS Drugs; 2022 Jun; 36(6):605-616. PubMed ID: 35644903
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study.
Kahn RS; Kane JM; Correll CU; Arevalo C; Simmons A; Graham C; Yagoda S; Hu B; McDonnell D
J Clin Psychiatry; 2023 Mar; 84(3):. PubMed ID: 36946605
[No Abstract] [Full Text] [Related]
10. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine and samidorphan combination treatment: A systematic review.
Jawad MY; Alnefeesi Y; Lui LMW; Ceban F; Chen-Li DCJ; Teopiz K; Jaberi S; Gillissie ES; Vincenzo JDD; Rosenblat JD; McIntyre RS
J Affect Disord; 2022 Mar; 301():99-106. PubMed ID: 35007644
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.
Monahan C; McCoy L; Powell J; Gums JG
Ann Pharmacother; 2022 Sep; 56(9):1049-1057. PubMed ID: 35040357
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients.
Meyer JM; Simmons A; Jiang Y; Graham C; Yagoda S; McDonnell D
CNS Spectr; 2022 Oct; ():1-4. PubMed ID: 36226902
[TBL] [Abstract][Full Text] [Related]
14. Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate.
Sun L; Yagoda S; Yao B; Graham C; von Moltke L
Clin Drug Investig; 2020 Jan; 40(1):55-64. PubMed ID: 31584140
[TBL] [Abstract][Full Text] [Related]
15. A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects.
Sun L; McDonnell D; Yu M; Kumar V; von Moltke L
Clin Drug Investig; 2019 May; 39(5):477-484. PubMed ID: 30888624
[TBL] [Abstract][Full Text] [Related]
16. Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.
Correll CU; Newcomer JW; Silverman B; DiPetrillo L; Graham C; Jiang Y; Du Y; Simmons A; Hopkinson C; McDonnell D; Kahn RS
Am J Psychiatry; 2020 Dec; 177(12):1168-1178. PubMed ID: 32791894
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and durability of effect with a combination of olanzapine and samidorphan in patients with schizophrenia: results from a 1-year open-label extension study.
Yagoda S; Graham C; Simmons A; Arevalo C; Jiang Y; McDonnell D
CNS Spectr; 2021 Aug; 26(4):383-392. PubMed ID: 32393412
[TBL] [Abstract][Full Text] [Related]
18. In vivo Characterization of the Opioid Receptor-Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations.
Tan LA; Gajipara N; Sun L; Bacolod M; Zhou Y; Namchuk M; Cunningham JI
Neuropsychiatr Dis Treat; 2022; 18():2497-2506. PubMed ID: 36345421
[TBL] [Abstract][Full Text] [Related]
19. A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension.
Kahn RS; Silverman BL; DiPetrillo L; Graham C; Jiang Y; Yin J; Simmons A; Bhupathi V; Yu B; Yagoda S; Hopkinson C; McDonnell D
Schizophr Res; 2021 Jun; 232():45-53. PubMed ID: 34015555
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
